28bio

Predict neurological response with human CNS & PNS organoids.

28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to improve the success rate of neurological therapies in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit 28bio.com.